Tuesday, November 18, 2025
Behance Facebook Instagram Linkedin Twitter Vimeo VKontakte Youtube
Home 2023

Yearly Archives: 2023

Biotech News

Adial (ADIL). Don’t Give up Drinking. Just Drink Less!

Editor / Curator -
Biotech News

Citius Pharma (CTXR) to Merge Subsidiary, with Publicly Traded SPAC TenX...

Editor / Curator -
2023 Watch List

Ardelyx (ARDX) $3.40, Receives FDA Approval.

Editor / Curator -
Hollywood Stock Review
Hollywood Stock Review

Adding Dolphin Entertainment (DLPN) to the Watch List

Editor / Curator -
All News

Adding Paramount (PARA) $12 to the Watch List.

Editor / Curator -
Marijuana Stock Review

Vext Science and Cannabis (VEXTF) Sells Prescott Cultivation Facility for $6.5...

Editor / Curator -
All News

Thumzup Media (TZUP) Ascends to Top 6.3% of All Active Reg...

Editor / Curator -
All News

Yuengling (YCRM) and PickleJar Announce Update to Complete Proposed Business Combination.

Editor / Curator -
Internet News

EyeOnChannel Production Studio & Network

Editor / Curator -
Conferences

Top Presenters, Dawson James 8th Annual Investor Conference.

Editor / Curator -
1...456...18Page 5 of 18

Latest article

Churchill Capital (CCCX) Infleqtion Merger.

AI Artificial Intelligence Editor / Curator -
Interview with Quantum Computing - Infleqtion CEO Matt Kinsella “I personally believe quantum is going to be a very important technological shift for humanity over...

Get Ready: Gold Crash To $3,500, Bitcoin To Collapse 90% | Mike McGlone

All News Editor / Curator -
https://youtu.be/ckZBaOOU2HM?si=ombBsU0caFKlRkEb

AI Powered Cyber Criminals Are Here. Are You Prepared?

AI Artificial Intelligence Editor / Curator -
15 Page Report on Sekur Private Data (SWISF) We've think we've come up with a way to make some money, and protect ourselves from AI...
The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
Contact us: roland@institutionalanalyst.com
© Managed by Revelers.IO Media Group Inc.